Navigation Links
eltrombopag in Medical News

Novel therapeutic approaches may improve patient outcomes in several platelet disorders

...l transfusions were the same in both arms. Oral eltrombopag for the Long-Term Treatment of Patients With Chron... multicenter, phase III study found that long-term eltrombopag therapy compared with placebo treatment significan...icroliters. They were randomized to receive either eltrombopag at a starting dose of 50 mg once daily (135 patien...

PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL

...ewed studies evaluating the safety and efficacy of eltrombopag in the short-term setting. Clinical data were presented and discussed that support eltrombopag increased platelet counts and reduced bleeding. ...ne Development Center at GSK. "An FDA approval for eltrombopag would represent an important development for these...

GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder

...s an increased risk of bruising and bleeding.(1,2) eltrombopag is an investigational, once-daily oral treatment t...it a Marketing Authorization Application (MAA) for eltrombopag in Europe in 2008. About the Data Submitted ...enna, Austria. At the end of the trial, 59% of eltrombopag treated patients on the 50mg dose and 16% of place...

Eltrombopag studied in Idiopathic Thrombocytopenic Purpura

...investigational oral platelet growth factor called eltrombopag successfully increased platelet counts and decreas...ind for ITP patients, the Phase 2 study found that eltrombopag doses of 50 and 75 mg daily elevated platelet coun... of adverse effects was similar in the placebo and eltrombopag treated groups. "These findings represent an im...

Drug May Help Reverse Clotting Deficiency

... eltrombopag might also aid patients with hepatitis liver disea... begin antiviral therapy for their condition after eltrombopag raised their platelet counts. "Eltrombopag is ...ly bleeding and bruising," Schwartz explained. eltrombopag is thought to stimulate megakaryocytes, the bone m...

GSK’s New Anticancer Drug A Huge Success In Drug trail

...y small, is likely to be transformed next year with the launch of Tykerb and other blockbuster drugs, such as the cervical cancer vaccine Cervarix and eltrombopag that is a blood-clotting agent in the treatment of breast cancer. They are also developing a lung cancer vaccine that would stop the disease from spre...
eltrombopag in Medical Technology

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

...fusions were the same in both arms. Oral eltrombopag for the Long-Term Treatment of Patients With Chron... multicenter, phase III study found that long-term eltrombopag therapy compared with placebo treatment significan...icroliters. They were randomized to receive either eltrombopag at a starting dose of 50 mg once daily (135 patien...

GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP

...hKline. GSK plans to submit a Marketing Authorization Application (MAA) for eltrombopag in Europe in 2008. Important Safety Information BOXED WARNI... to therapy with PROMACTA. Cataracts were observed in toxicology studies of eltrombopag in rodents. Perform a baseline ocular examination prior to administration o...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

... GSK plans to submit a Marketing Authorization Application (MAA) for eltrombopag in the treatment of chronic ITP in Europe in 2008; the proposed trade name ... to therapy with PROMACTA. Cataracts were observed in toxicology studies of eltrombopag in rodents. Perform a baseline ocular examination prior to administration o...

GSK Update on FDA Review of Promacta(R) (Eltrombopag)

...May 30, the Oncology Drugs Advisory Committee unanimously voted, 16-0, that eltrombopag demonstrated a favorable risk-benefit profile for the short-term treatment ...pivotal studies, the most common adverse events observed in patients taking eltrombopag were headache, common cold, and nausea. About GlaxoSmithKline GlaxoSmit...

FDA Grants Priority Review for PROMACTA(R) (eltrombopag)

...it a Marketing Authorization Application (MAA) for eltrombopag in the treatment of chronic ITP in Europe in 2008 ...se are rare.(1) About PROMACTA (eltrombopag) eltrombopag is an oral, non-peptide thrombopoietin receptor ag...ne marrow cells that give rise to blood platelets. eltrombopag was discovered as a result of research collaborati...

Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting

...iries: Frank Murdolo 215-751-7002 Tom Curry 215-751-5419 REFERENCES (1) Bussel, JB., Cheng, G., et al. Long-term safety and efficacy of oral eltrombopag for the treatment of subjects with idiopathic thrombocytopenic purpura (ITP): preliminary data from the EXTEND study. Blood. 2007; 110 (11). Published...

Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP

...189 patients across 135 centers in 26 countries. REPEAT (Repeat ExPosure to eltrombopag in Adults with Idiopathic Thrombocytopenic Purpura) will involve 50 patient...51 5419 REFERENCES (1) Bussel, J., Provan A., Shamsi T et al. eltrombopag Raises Platelet Count and Reduces Bleeding compared with Placebo ...
eltrombopag in Biological News

Lancet study supports new, highly effective treatment for blood disorder

...ed late 2007 in the New England Journal of Medicine. This trial showed that eltrombopag was effective in raising platelet counts and lowering bleeding in adult sub...cts. Ongoing and future studies will evaluate the safety and efficacy of eltrombopag as a long-term treatment for ITP, and its efficacy and safety in population...

Eltrombopag effective for hepatitis C patients with low blood-platelet counts

...the door to effective treatment. "In this study, eltrombopag increased platelet counts in a dose-dependent mann...common reason for a liver transplant. With other eltrombopag findings, NewYork-Presbyterian/Weill Cornell's Dr.... GlaxoSmithKline, which is developing eltrombopag. eltrombopag (marketed as Promacta in the U.S. and Revolade in ...
Other Tags
(Date:7/29/2014)... All brides want their bridal dresses and bridal ... collection is sure to provide designs of wedding gowns ... stores. It has recently announced its new collection of ... new products come with big savings, up to 61% ... have been working in the garment industry for several ...
(Date:7/28/2014)... NY (PRWEB) July 29, 2014 ... Nurse at Kings County Hospital Center, as a 2014 ... with this prestigious distinction for leadership in community health. ... the country, spanning virtually every industry and profession, the ... vibrant networking community with over 600,000 members and nearly ...
(Date:7/28/2014)... 29, 2014 The “Tissue ... Hybridization, Digital pathology & Workflow, Special Staining), ... Cancer, Non Small Cell Lung Cancer and ... Pharmaceutical companies, Research Laboratories, Contract Research Organizations ... Europe, BRIC, Japan & RoW) - Trends ...
(Date:7/28/2014)... Camp Soaring Eagle today announced it ... Cornville, AZ. The nonprofit organization, founded in July ... to attend medically supervised camps at no cost ... a variety of programs to Arizona families and ... illnesses including: Illness Specific Camping Weekends, Illness Specific ...
(Date:7/28/2014)... An estimated 68,000 women and men in the ... cancers – an aggressive form of the disease that ... of the body, such as the lungs, liver, bones, ... of Medicine have developed a compound directed at ... blocking tumor cells from “re-seeding.” Their discovery has been ...
Breaking Medicine News(10 mins):Health News:LunaDress’ Summer Sale Has Arrived: All Its Gorgeous Lace Wedding Dresses are Affordable Now 2Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 3
(Date:7/28/2014)... other forms of dementia, but the research community is ... Washington bioengineers have a designed a peptide structure that ... proteins into a state that,s linked to widespread diseases ... and Lou Gehrig,s disease. The synthetic molecule blocks these ... an abnormally folded form by targeting a toxic intermediate ...
(Date:7/28/2014)... (July 28, 2014) Rice University researchers are ... of varying flexibility that can be used as microscale ... proof that "bead-spring" polymers, introduced as theory in the ... as required and should be of interest to materials ... The work led by Rice chemical and biomolecular engineer ...
(Date:7/28/2014)... many of these due to genetic factors. This is ... which reduce an individual,s ability to reproduce, to disappear ... Science that recently appeared in Nature Communications ... it explain the high rates of male fertility problems, ... of genetic diseases and their treatment. , Various ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Seeing is bead-lieving 2Mutations from Venus, mutations from Mars 2
Other Contents